These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10837444)

  • 1. Detection of extended-spectrum beta-lactamases in members of the family enterobacteriaceae: comparison of the MAST DD test, the double disc and the Etest ESBL.
    M'Zali FH; Chanawong A; Kerr KG; Birkenhead D; Hawkey PM
    J Antimicrob Chemother; 2000 Jun; 45(6):881-5. PubMed ID: 10837444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
    Mohanty S; Gaind R; Ranjan R; Deb M
    J Infect Dev Ctries; 2009 Nov; 4(1):24-9. PubMed ID: 20130375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
    Stürenburg E; Sobottka I; Noor D; Laufs R; Mack D
    J Antimicrob Chemother; 2004 Jul; 54(1):134-8. PubMed ID: 15150168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
    Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
    J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide.
    Drieux L; Brossier F; Sougakoff W; Jarlier V
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():90-103. PubMed ID: 18154532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic expression and prevalence of ESBL-producing Enterobacteriaceae in samples collected from patients in various wards of Mulago Hospital, Uganda.
    Kateregga JN; Kantume R; Atuhaire C; Lubowa MN; Ndukui JG
    BMC Pharmacol Toxicol; 2015 Jun; 16():14. PubMed ID: 26031914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic detection of AmpC β-lactamases, extended-spectrum β-lactamases and metallo-β-lactamases in Enterobacteriaceae using a resazurin microtitre assay with inhibitor-based methods.
    Teethaisong Y; Eumkeb G; Chumnarnsilpa S; Autarkool N; Hobson J; Nakouti I; Hobbs G; Evans K
    J Med Microbiol; 2016 Oct; 65(10):1079-1087. PubMed ID: 27481506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the effectiveness of three different cephalosporin/clavulanate combinations for the phenotypic confirmation of extended-spectrum beta-lactamase producing bacteria isolated from urine samples at National Public Health Laboratory, Kathmandu, Nepal.
    Bhandari R; Pant ND; Poudel A; Sharma M
    BMC Res Notes; 2016 Aug; 9():390. PubMed ID: 27488224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
    Jayahar Bharathi M; Ramakrishnan R; Ramesh S; Murugan N
    Ophthalmic Res; 2012; 47(1):52-6. PubMed ID: 21720185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rapid detection of extended-spectrum beta-lactamases by flow cytometry method].
    Duyan S; Kılıç A; Yılmaz S; Ardıç N
    Mikrobiyol Bul; 2015 Oct; 49(4):600-8. PubMed ID: 26649418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a novel, inhibitor-potentiated disc-diffusion test with other methods for the detection of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae.
    Ho PL; Chow KH; Yuen KY; Ng WS; Chau PY
    J Antimicrob Chemother; 1998 Jul; 42(1):49-54. PubMed ID: 9700527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of extended-spectrum beta-lactamases in Enterobacteriaceae isolated from hospitalized patients in Curitiba, southern Brazil.
    Nogueira Kda S; Higuti IH; do Nascimento AJ; Terasawa LB; de Oliveira S; Matos AP; de Souza HA; Cogo LL; Dalla Costa LM
    Braz J Infect Dis; 2006 Dec; 10(6):390-5. PubMed ID: 17420911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of different phenotypic methods detecting extended spectrum beta-lactamases in Pseudomonas aeruginosa and Acinetobacter baumannii strains].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2005 Jul; 39(3):265-72. PubMed ID: 16358485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation in zone of inhibition of cefoperazone/cefoperazone+ sulbactum compares well with the clinical laboratory standard institute standard extended spectrum beta-lactamase detection method as well as the polymerase chain reaction method.
    Chitnis S; Katara G; Hemvani N; Chitnis DS
    Curr Drug Saf; 2011 Jul; 6(3):155-8. PubMed ID: 22122390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of extended-spectrum beta-lactamases in Enterobacter cloacae in Taiwan and comparison of 3 phenotypic confirmatory methods for detecting extended-spectrum beta-lactamase production.
    Yang JL; Wang JT; Lauderdale TL; Chang SC
    J Microbiol Immunol Infect; 2009 Aug; 42(4):310-6. PubMed ID: 19949754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of favorable oral cephalosporin-clavulanate interactions by in vitro disk approximation susceptibility testing of extended-spectrum-Beta-lactamase-producing members of the enterobacteriaceae.
    Campbell JD; Lewis JS; McElmeel ML; Fulcher LC; Jorgensen JH
    J Clin Microbiol; 2012 Mar; 50(3):1023-6. PubMed ID: 22170910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen.
    Cormican MG; Marshall SA; Jones RN
    J Clin Microbiol; 1996 Aug; 34(8):1880-4. PubMed ID: 8818874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The performance of a resazurin chromogenic agar plate with a combined disc method for rapid screening of extended-spectrum-β-lactamases, AmpC β-lactamases and co-β-lactamases in Enterobacteriaceae.
    Teethaisong Y; Evans K; Nakouti I; Tiamyom K; Ketudat-Cairns JR; Hobbs G; Eumkeb G
    Microbiol Immunol; 2017 Aug; 61(8):297-304. PubMed ID: 28685856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producers.
    Livermore DM; Hope R; Mushtaq S; Warner M
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():189-93. PubMed ID: 18154546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.